3320.HK

China Resources Pharmaceutical Group Limited [3320.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

3320.HK Stock Summary

Top 10 Correlated ETFs

3320.HK


Top 10 Correlated Stocks

3320.HK


In the News

3320.HK Financial details

Company Rating
Strong Buy
Market Cap
32.29B
Income
8.52B
Revenue
515.36B
Book val./share
8.02
Cash/share
6.22
Dividend
0.16
Dividend %
3.07%
Employees
71K
Optionable
No
Shortable
Yes
Earnings
26 Mar 2024
P/E
4.18
Forward P/E
5.56
PEG
0.33
P/S
0.13
P/B
0.66
P/C
0.8
P/FCF
3.59
Quick Ratio
0.38
Current Ratio
1.25
Debt / Equity
1.78
LT Debt / Equity
0.13
-
-
EPS (TTM)
1.35
EPS next Y
0.9
EPS next Q
-
EPS this Y
10%
EPS next Y
-33.11%
EPS next 5Y
-33.11%
EPS last 5Y
0.62%
Revenue last 5Y
6.02%
Revenue Q/Q
8.22%
EPS Q/Q
166.67%
-
-
-
-
SMA20
-3.94%
SMA50
-1.73%
SMA100
5.35%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
16%
ROC
0.13%
Gross Margin
15%
Oper. Margin
5%
Profit Margin
3%
Payout
12%
Shs Outstand
6.28B
Shs Float
1.69B
-
-
-
-
Target Price
-
52W Range
4.45-8.13
52W High
-37.5%
52W Low
+25%
RSI
44
Rel Volume
1.8
Avg Volume
8.23M
Volume
14.84M
Perf Week
-0.6%
Perf Month
2.46%
Perf Quarter
0.81%
Perf Half Y
-3.47%
-
-
-
-
Beta
0.363
-
-
Volatility
0.08%, 0.12%
Prev Close
-1.77%
Price
5
Change
-3.29%

3320.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
30.1832.5331.937.6940.45
Net income per share
0.640.520.520.60.66
Operating cash flow per share
1.310.8411.791.73
Free cash flow per share
1.070.510.651.321.2
Cash per share
7.113.638.335.945.18
Book value per share
6.266.487.48.117.89
Tangible book value per share
5.824.065.035.885.87
Share holders equity per share
6.266.487.48.117.89
Interest debt per share
10.539.019.6513.4310.98
Market cap
64.23B45.44B25.07B22.3B39.71B
Enterprise value
110.81B82.82B65.98B79.56B82.58B
P/E ratio
15.9113.837.65.929.57
Price to sales ratio
0.340.220.130.090.16
POCF ratio
7.798.653.991.993.64
PFCF ratio
9.5414.146.182.685.26
P/B Ratio
1.631.120.540.440.8
PTB ratio
1.631.120.540.440.8
EV to sales
0.580.410.330.340.33
Enterprise value over EBITDA
9.267.976.056.595.91
EV to operating cash flow
13.4415.7610.517.097.58
EV to free cash flow
16.4625.7716.269.5710.95
Earnings yield
0.060.070.130.170.1
Free cash flow yield
0.10.070.160.370.19
Debt to equity
1.611.31.241.61.33
Debt to assets
0.360.280.270.330.27
Net debt to EBITDA
3.893.63.754.743.07
Current ratio
1.231.251.21.251.25
Interest coverage
3.552.162.683.413.79
Income quality
2.071.61.92.982.63
Dividend Yield
0.010.020.030.030.02
Payout ratio
0.170.250.210.20.23
Sales general and administrative to revenue
0.020.030.030.030.03
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.140.240.230.240.22
Capex to operating cash flow
-0.18-0.39-0.35-0.26-0.31
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-1-0.86-0.91-1.03-1.06
Stock based compensation to revenue
00000
Graham number
9.518.739.3410.4710.82
ROIC
0.080.060.060.050.07
Return on tangible assets
0.030.020.020.020.02
Graham Net
-3.95-3.62-2.26-3.43-4.12
Working capital
23.91B26.27B24.49B35.29B34.13B
Tangible asset value
36.6B25.52B31.6B36.94B36.86B
Net current asset value
11.55B13.1B18.42B23.92B20.22B
Invested capital
1.611.31.241.61.33
Average receivables
53.11B65.71B75.3B85.88B103.96B
Average payables
40.87B34.51B30.35B34.48B38.73B
Average inventory
21.47B21.93B23.46B27.14B29.7B
Days sales outstanding
90.94150.24121.01162.31147.4
Days payables outstanding
93.2263.1567.7868.467.43
Days of inventory on hand
50.7747.8353.3753.850.46
Receivables turnover
4.012.433.022.252.48
Payables turnover
3.925.785.395.345.41
Inventory turnover
7.197.636.846.787.23
ROE
0.10.080.070.070.08
Capex per share
-0.24-0.32-0.35-0.46-0.53

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
18.2219.4720.0120.4422.12
Net income per share
0.390.210.480.180.48
Operating cash flow per share
-0.332.12-0.72.43-0.88
Free cash flow per share
-0.481.81-0.952.16-1.1
Cash per share
9.455.946.125.186.22
Book value per share
7.758.118.057.898.02
Tangible book value per share
5.55.885.865.876.29
Share holders equity per share
7.758.118.057.898.02
Interest debt per share
13.0713.214.3210.7614.54
Market cap
30.41B22.3B33.49B39.71B42.85B
Enterprise value
87.8B79.56B97.09B82.58B101.17B
P/E ratio
3.124.192.778.843.53
Price to sales ratio
0.270.180.270.310.31
POCF ratio
-14.531.68-7.672.6-7.79
PFCF ratio
-10.011.96-5.582.93-6.2
P/B Ratio
0.620.440.660.80.85
PTB ratio
0.620.440.660.80.85
EV to sales
0.770.650.770.640.73
Enterprise value over EBITDA
12.9615.0211.814.411.56
EV to operating cash flow
-41.955.98-22.225.41-18.4
EV to free cash flow
-28.97.01-16.196.1-14.63
Earnings yield
0.080.060.090.030.07
Free cash flow yield
-0.10.51-0.180.34-0.16
Debt to equity
1.661.61.751.331.78
Debt to assets
0.340.330.350.270.33
Net debt to EBITDA
8.4710.817.737.486.66
Current ratio
1.211.251.271.251.26
Interest coverage
3.673.074.862.84.35
Income quality
-0.8610-1.4413.6-1.81
Dividend Yield
0.02000.020
Payout ratio
0.31000.840
Sales general and administrative to revenue
0.020.030.020.030.02
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.210.240.220.220.2
Capex to operating cash flow
0.45-0.150.37-0.110.26
Capex to revenue
-0.01-0.02-0.01-0.01-0.01
Capex to depreciation
-0.69-1.34-1.02-1.11-0.83
Stock based compensation to revenue
00000
Graham number
8.226.229.345.639.34
ROIC
0.030.020.040.030.04
Return on tangible assets
0.010.010.020.010.01
Graham Net
-2.77-3.43-3.96-4.12-4.87
Working capital
30.09B35.29B40.17B34.13B41.2B
Tangible asset value
34.53B36.94B36.84B36.86B39.49B
Net current asset value
20.87B23.92B23.73B20.22B23.59B
Invested capital
1.661.61.751.331.78
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
62.2877.4881.5571.9377.98
Days payables outstanding
34.5932.5434.8632.7735.49
Days of inventory on hand
25.1625.5924.7224.5226.93
Receivables turnover
1.441.161.11.251.15
Payables turnover
2.62.772.582.752.54
Inventory turnover
3.583.523.643.673.34
ROE
0.050.030.060.020.06
Capex per share
-0.15-0.31-0.26-0.27-0.23

3320.HK Frequently Asked Questions

What is China Resources Pharmaceutical Group Limited stock symbol ?

China Resources Pharmaceutical Group Limited is a HK stock and trading under the symbol 3320.HK

What is China Resources Pharmaceutical Group Limited stock quote today ?

China Resources Pharmaceutical Group Limited stock price is $5 today.

Is China Resources Pharmaceutical Group Limited stock public?

Yes, China Resources Pharmaceutical Group Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap